Muscular Dystrophy News and Research

RSS
The muscular dystrophies (MD) are a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement. Some forms of MD are seen in infancy or childhood, while others may not appear until middle age or later. The disorders differ in terms of the distribution and extent of muscle weakness (some forms of MD also affect cardiac muscle), age of onset, rate of progression, and pattern of inheritance.
New cellular entry pathway improves gene therapy outcomes

New cellular entry pathway improves gene therapy outcomes

Uncovering the hidden architecture of the genome in three dimensions

Uncovering the hidden architecture of the genome in three dimensions

Improving RNA drug delivery through intracellular traffic control

Improving RNA drug delivery through intracellular traffic control

Researchers reverse muscle stem cell aging with Prostaglandin E2

Researchers reverse muscle stem cell aging with Prostaglandin E2

Experimental ALS drug shows unprecedented recovery in some patients

Experimental ALS drug shows unprecedented recovery in some patients

AAN releases Evidence in Focus Article on new gene therapy for Duchenne muscular dystrophy

AAN releases Evidence in Focus Article on new gene therapy for Duchenne muscular dystrophy

Estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue

Estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue

Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy

Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy

Antimalarial drug enhances effect of aminoglycosides in genetic disorders

Antimalarial drug enhances effect of aminoglycosides in genetic disorders

Researchers uncover genetic link between autism spectrum disorder and myotonic dystrophy type 1

Researchers uncover genetic link between autism spectrum disorder and myotonic dystrophy type 1

Trump’s DEI undoing undermines hard-won accommodations for disabled people

Trump’s DEI undoing undermines hard-won accommodations for disabled people

New protein target could aid in muscle regeneration for degenerative conditions

New protein target could aid in muscle regeneration for degenerative conditions

Many people with disabilities risk losing their Medicaid if they work too much

Many people with disabilities risk losing their Medicaid if they work too much

Testing a novel approach to restore normal heart function in Myotonic Dystrophy Type 1

Testing a novel approach to restore normal heart function in Myotonic Dystrophy Type 1

Research links kidney dysfunction to muscle weakness in myotonic dystrophy type 1

Research links kidney dysfunction to muscle weakness in myotonic dystrophy type 1

Protein cluster discovery could lead to muscular dystrophy treatments

Protein cluster discovery could lead to muscular dystrophy treatments

Study sheds light on the role of fibro-adipogenic progenitors in muscle regeneration and degeneration

Study sheds light on the role of fibro-adipogenic progenitors in muscle regeneration and degeneration

New mRNA technique targets disease cells while sparing healthy ones

New mRNA technique targets disease cells while sparing healthy ones

Communication between body muscle and pituitary gland may play unexpected role in female fertility

Communication between body muscle and pituitary gland may play unexpected role in female fertility

SPLICER shows promise in Alzheimer's and other diseases

SPLICER shows promise in Alzheimer's and other diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.